Jesçs Rivera-Nieves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jesçs Rivera-Nieves has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Eoin N. McNamee
Neuroimmunology Research Group, Trinity College Institute of Neuroscience, Department of Physiology & School of Medicine, Trinity College, Dublin 2, Ireland
3 shared publications Colm B. Collins
Mucosal Inflammation Program, Division of Gastroenterology, University of Colorado Health Sciences Center, Denver
2 shared publicationsMatthew D.P. Lebsack
Mucosal Inflammation Program, Division of Gastroenterology, University of Colorado Health Sciences Center, Denver
2 shared publicationsColm B Collins
Mucosal Inflammation Program, Division of Gastroenterology, Department of Internal Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80045, USA
1 shared publicationGlenn T. Furuta
†Gastrointestinal Eosinophilic Disease Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, The Children’s Hospital, School of Medicine, University of Colorado, Denver
1 shared publicationJames J. Lee
‡Division of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona
1 shared publication
Latest Publications
- 1 May 2010
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 16 (5) , 743-752
Novel model of TH2-polarized chronic ileitis: The SAMP1 mouse
Background. SAMP1/Yit mice develop spontaneous, segmental, transmural ileitis recapitulating many features of Crohn's disease (CD). The ileitic phenoty
- 1 May 2010
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 16 (5) , 743-752
Novel model of TH2-polarized chronic ileitis: The SAMP1 mouse
Background. SAMP1/Yit mice develop spontaneous, segmental, transmural ileitis recapitulating many features of Crohn's disease (CD). The ileitic phenoty
- Open Access
- 30 April 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (4) , 1237-1239
Cell-Specific Inhibition of p38α as a Therapeutic Strategy for Inflammatory Bowel Disease
- 30 April 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (4) , 1237-1239
Open AccessCell-Specific Inhibition of p38α as a Therapeutic Strategy for Inflammatory Bowel Disease